Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Livingstone

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Journal of Inflammation (London, England)|March 21, 2025
Semaphorin 7a is protective through immune modulation during acetaminophen-induced liver injuryEilidh J Livingstone, Jennifer A Cartwright, Lara Campana, et al.
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 25, 2013
Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from ScotlandEleanor J Hothersall, Shona J Livingstone, Helen C Looker, et al.
Metabolism: Clinical and Experimental|April 23, 2023
MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studiesShilpa R Nagarajan, Eilidh J Livingstone, Thomas Monfeuga, et al.
Diabetologia|October 31, 2008
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)V Charlton-Menys, D J Betteridge, H Colhoun, et al.
Clinical Chemistry|January 17, 2009
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)Valentine Charlton-Menys, D John Betteridge, Helen Colhoun, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 14, 2020
A Monte Carlo model of synchrotron radiotherapy shows good agreement with experimental dosimetry measurements: Data from the imaging and medical beamline at the Australian SynchrotronL R J Day, P Pellicioli, F Gagliardi, et al.
International Journal of Epidemiology|March 25, 2017
Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO)Tahira Akbar, Stuart McGurnaghan, Colin N A Palmer, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of Inflammation (London, England)|March 21, 2025
Semaphorin 7a is protective through immune modulation during acetaminophen-induced liver injuryEilidh J Livingstone, Jennifer A Cartwright, Lara Campana, et al.
Lancet (London, England)|August 25, 2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialHelen M Colhoun, D John Betteridge, Paul N Durrington, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
Neuro-Oncology|March 6, 2020
Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccineConnor J Liu, Maximilian Schaettler, Dylan T Blaha, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 25, 2013
Contemporary risk of hip fracture in type 1 and type 2 diabetes: a national registry study from ScotlandEleanor J Hothersall, Shona J Livingstone, Helen C Looker, et al.
Metabolism: Clinical and Experimental|April 23, 2023
MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studiesShilpa R Nagarajan, Eilidh J Livingstone, Thomas Monfeuga, et al.
Diabetologia|October 31, 2008
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)V Charlton-Menys, D J Betteridge, H Colhoun, et al.
Clinical Chemistry|January 17, 2009
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)Valentine Charlton-Menys, D John Betteridge, Helen Colhoun, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 14, 2020
A Monte Carlo model of synchrotron radiotherapy shows good agreement with experimental dosimetry measurements: Data from the imaging and medical beamline at the Australian SynchrotronL R J Day, P Pellicioli, F Gagliardi, et al.
International Journal of Epidemiology|March 25, 2017
Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO)Tahira Akbar, Stuart McGurnaghan, Colin N A Palmer, et al.
Pageof 14